Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)
海湾南部少数民族/服务不足的临床试验网络(海湾南部 M/U CTN)
基本信息
- 批准号:10675065
- 负责人:
- 金额:$ 227.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgreementBirdsBone Marrow TransplantationBreastCancer CenterCancer ControlCancer PatientCaringCervicalClinical TrialsClinical Trials NetworkCommunitiesCommunity HealthCommunity ParticipationCommunity PhysicianDedicationsDevelopmentDiseaseDisparityFederally Qualified Health CenterFundingGoalsHIV/AIDSHealthHealth Disparities ResearchHealth PersonnelHealth care facilityHospital AdministrationHospitalsInequityInstitutionLeadershipLouisianaMalignant NeoplasmsMinorityMinority ParticipationOutcomePatient ParticipationPatientsPediatric OncologyPilot ProjectsPreventionProviderRegistriesResearchResearch PersonnelResourcesRural CommunityScreening for cancerSiteTestingUnited States Department of Veterans AffairsWomanWomen&aposs Healthcancer carecancer clinical trialcancer health disparityclinical centercommunity organizationsexperiencehealth disparityimprovedminority patientmultidisciplinarynew technologynovelnovel strategiesoncology programprogramsreferral servicesrural areascreening programtreatment disparitytreatment trialtumorunderserved minority
项目摘要
ABSTRACT
The Gulf South Minority/Underserved – NCORP (GS-M/U-NCORP) and the Ochsner-Community-NCORP, the
two NCORPs in Louisiana, have both met the objectives proposed for the last funding cycle, expanding access
to and significantly increasing the number of patients participating in clinical trials in Louisiana and the Gulf
South region. These successful NCORPs have agreed to come together to form the Gulf South
Minority/Underserved Clinical Trials Network (Gulf South M/U CTN) NCORP, which will have as its primary
affiliates the LSU – Cancer Center New Orleans (LSU-CC-New Orleans), LSU – Feist Weiller Cancer Center
Shreveport (LSU-FWCC-Shreveport), Mary Bird Perkins Cancer Center (MBPCC) and the Ochsner-Cancer
Center (Ochsner). The new Gulf South M/U CTN will provide cancer care and access to clinical trials for >50%
of new cancer cases in the region, expand the number of sites offering access to clinical trials from 22 to 42,
and exceed the required 30% proportion of minority patients participating in NCORP trials. The Gulf South
M/U CTN will bring additional resources including the Louisiana Tumor SEER registry (LTR-SEER) and the
state-wide cancer screening programs such as the Louisiana Breast and Cervical Health Program (LBCHP),
and the Louisiana Comprehensive Cancer Control Program (LCCCP). In addition we will benefit from ongoing
research led by our investigators and aimed at understanding cancer inequities and disparities in our region.
The new Gulf South M/U CTN has also expanded its network with major health providers in the region
including the Veterans Administration Hospital (New Orleans), Woman's Hospital (the largest dedicated clinical
center for women's health) in Baton Rouge and the Christus Health community sites. The new Gulf South M/U
CTN has garnered the support of the Louisiana Department of Health Secretary and the Governor, who are
developing a cancer care plan for the state (Taking Aim at Cancer in Louisiana Collaborative -TACL), where
the Gulf South M/U CTN is the major provider of state-wide cancer clinical trials. This support will help us to
continue increasing the participation of patients in NCORP and non-NCORP studies. To achieve our goals we
will implement the following three strategies. 1. Expand the number of sites through additional partnerships
with community organizations such as FQHC's where we will test novel approaches to increase the
participation of community physicians providing care to cancer patients in the region; 2. Support the
development of CCDR and Health Disparities research initiated by our investigators to understand the
inequities created by cancer in our region and 3. Increase our participation in national trials supported by
NCORP and other organizations to expand the scope and depth of trials offered to our patients.
摘要
海湾南部少数民族/服务不足者- NCORP(GS-M/U-NCORP)和Ochsner社区-NCORP,
路易斯安那州的两个NCORPs都达到了上一个资助周期提出的目标,
并显著增加了路易斯安那州和海湾地区参与临床试验的患者数量
南区。这些成功的NCORPs同意联合起来组成海湾南部
少数/服务不足的临床试验网络(海湾南部M/U CTN)NCORP,将其主要
附属机构路易斯安那州立大学-新奥尔良癌症中心(LSU-CC-新奥尔良),路易斯安那州立大学- Feist Weiller癌症中心
什里夫波特(LSU-FWCC-什里夫波特)、玛丽伯德帕金斯癌症中心(MBPCC)和奥克斯纳癌症中心
中心(奥克斯纳)。新的海湾南部M/U CTN将为>50%的人提供癌症护理和临床试验
增加该地区新的癌症病例,将提供临床试验的网站数量从22个增加到42个,
并超过参与NCORP试验的少数民族患者所需的30%比例。海湾南部
M/U CTN将带来额外的资源,包括路易斯安那州肿瘤SEER登记(LTR-SEER)和
全州范围的癌症筛查计划,如路易斯安那州乳腺和宫颈健康计划(LBCHP),
路易斯安那州综合癌症控制计划(LCCCP)此外,我们将受益于持续的
研究由我们的研究人员领导,旨在了解我们地区的癌症不平等和差异。
新的海湾南部M/U CTN还扩大了与该地区主要医疗服务提供者的网络
包括退伍军人管理医院(新奥尔良),妇女医院(最大的专门临床
巴吞鲁日妇女健康中心)和基督健康社区站点。新海湾南部M/U
CTN已经获得了路易斯安那州卫生部长和州长的支持,他们是
为该州制定一项癌症护理计划(路易斯安那州针对癌症合作组织-TACL),其中
墨西哥湾南部M/U CTN是全州癌症临床试验的主要提供者。这种支持将帮助我们
继续增加患者参与NCORP和非NCORP研究。为了实现我们的目标,
将实施以下三项战略。1.通过更多的伙伴关系扩大网站数量
与社区组织,如CIMHC的,我们将测试新的方法,以增加
社区医生参与为该地区癌症患者提供护理; 2.支持
由我们的研究人员发起的CCDR和健康差异研究的发展,以了解
癌症在我们地区造成的不平等; 3.增加我们对国家试验的参与,
NCORP和其他组织,以扩大为我们的患者提供的试验的范围和深度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AUGUSTO C. OCHOA其他文献
AUGUSTO C. OCHOA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AUGUSTO C. OCHOA', 18)}}的其他基金
Project 2-Metabolic Modulation of Myeloid-Derived Suppressor Cells to Increase Efficacy of Neo adjuvant Chemotherapy and Immunotherapy
项目2-骨髓源性抑制细胞的代谢调节以提高新辅助化疗和免疫疗法的疗效
- 批准号:
10005254 - 财政年份:2018
- 资助金额:
$ 227.46万 - 项目类别:
Cell Immunology and Metabolism Core (CIMC)
细胞免疫学与代谢核心(CIMC)
- 批准号:
10223346 - 财政年份:2017
- 资助金额:
$ 227.46万 - 项目类别:
Mentoring Translational Researchers in Louisiana
指导路易斯安那州的转化研究人员
- 批准号:
8883035 - 财政年份:2015
- 资助金额:
$ 227.46万 - 项目类别:
Gulf South Minority-based NCI Community Oncology Research Program
海湾南部少数民族 NCI 社区肿瘤学研究计划
- 批准号:
9328027 - 财政年份:2014
- 资助金额:
$ 227.46万 - 项目类别:
Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)
海湾南部少数民族/服务不足的临床试验网络(海湾南部 M/U CTN)
- 批准号:
10197649 - 财政年份:2014
- 资助金额:
$ 227.46万 - 项目类别:
Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)
海湾南部少数民族/服务不足的临床试验网络(海湾南部 M/U CTN)
- 批准号:
10678186 - 财政年份:2014
- 资助金额:
$ 227.46万 - 项目类别:
Gulf South Minority-based NCI Community Oncology Research Program
海湾南部少数民族 NCI 社区肿瘤学研究计划
- 批准号:
8790613 - 财政年份:2014
- 资助金额:
$ 227.46万 - 项目类别:
相似海外基金
A study for cross borders Indonesian nurses and care workers: Case of Japan-Indonesia Economic Partnership Agreement
针对跨境印度尼西亚护士和护理人员的研究:日本-印度尼西亚经济伙伴关系协定的案例
- 批准号:
22KJ0334 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Challenges of the Paris Agreement Exposed by the Energy Shift by External Factors: The Case of Renewable Energy Policies in Japan, the U.S., and the EU
外部因素导致的能源转移对《巴黎协定》的挑战:以日本、美国和欧盟的可再生能源政策为例
- 批准号:
23H00770 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
NSF-NOAA Interagency Agreement (IAA) for the Global Oscillations Network Group (GONG)
NSF-NOAA 全球振荡网络组 (GONG) 机构间协议 (IAA)
- 批准号:
2410236 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Cooperative Agreement
Conditions for U.S. Agreement on the Closure of Contested Overseas Bases: Relations of Threat, Alliance and Base Alternatives
美国关于关闭有争议的海外基地协议的条件:威胁、联盟和基地替代方案的关系
- 批准号:
23K18762 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
MSI Smart Manufacturing Data Hub – Open Calls Grant Funding Agreement
MSI 智能制造数据中心 – 公开征集赠款资助协议
- 批准号:
900240 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Collaborative R&D
Continuation of Cooperative Agreement between U.S. Food and Drug Administration and S.C. Department of Health and Environmental Control (DHEC) for MFRPS Maintenance.
美国食品和药物管理局与南卡罗来纳州健康与环境控制部 (DHEC) 继续签订 MFRPS 维护合作协议。
- 批准号:
10829529 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
National Ecological Observatory Network Governing Cooperative Agreement
国家生态观测站网络治理合作协议
- 批准号:
2346114 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Cooperative Agreement
The Kansas Department of Agriculture's Flexible Funding Model Cooperative Agreement for MFRPS Maintenance, FPTF, and Special Project.
堪萨斯州农业部针对 MFRPS 维护、FPTF 和特别项目的灵活资助模式合作协议。
- 批准号:
10828588 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Robust approaches for the analysis of agreement between clinical measurements: development of guidance and software tools for researchers
分析临床测量之间一致性的稳健方法:为研究人员开发指南和软件工具
- 批准号:
MR/X029301/1 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Linguistic transfer in a contact variety of Spanish: Gender agreement production and attitudes
博士论文研究:西班牙语接触变体中的语言迁移:性别协议的产生和态度
- 批准号:
2234506 - 财政年份:2023
- 资助金额:
$ 227.46万 - 项目类别:
Standard Grant